DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis.

DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis.
复制标题

DPP-4 抑制剂可能会降低 2019 年冠状病毒病的死亡率:一项荟萃分析

DOI:
10.1371/journal.pone.0251916
复制
发表时间:
2021
期刊:
影响因子:
3.7
通讯作者:
Zhang J
Zhang J
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Yang Y;Cai Z;Zhang J

文献摘要

参考文献

被引文献

相似文献

预计DPP-4抑制剂对2019冠状病毒病(COVID-19)的进展具有保护作用。我们进行了这项荟萃分析来研究这一假设。四个数据库,即PubMed、Web of Science、EMBASE和科克伦图书馆,用于识别关于DPP-4和COVID-19的研究。结果指标为COVID-19的死亡率。采用漏斗图、Begg检验和Egger检验评估发表偏倚。纳入了4篇文章,共计1933例COVID-19和2型糖尿病患者。DPP-4抑制剂的使用与死亡风险呈负相关(比值比(OR)= 0.58 95%置信区间(CI),0.34-0.99)。DPP-4抑制剂可能会改善COVID-19和2型糖尿病患者的死亡率。由于相关研究很少,因此需要进行更多的大规模研究。
DPP-4 inhibitors are predicted to exert a protective effect on the progression of coronavirus disease 2019 (COVID-19). We conducted this meta-analysis to investigate this hypothesis. Four databases, namely, PubMed, Web of Science, EMBASE and the Cochrane Library, were used to identify studies on DPP-4 and COVID-19. The outcome indicators were the mortality of COVID-19. Funnel plots, Begg’s tests and Egger’s tests were used to assess publication bias. Four articles were included with a total of 1933 patients with COVID-19 and type 2 diabetes. The use of DPP-4 inhibitors was negatively associated with the risk of mortality (odds ratio (OR) = 0.58 95% confidence interval (CI), 0.34–0.99). DPP-4 inhibitors may improve the mortality of patients with COVID-19 and type 2 diabetes. As few relevant studies are available, more large-scale studies need to be performed.
DOI: 10.1038/nrmicro.2016.81
发表时间: 2016-08
期刊: Nature reviews. Microbiology
影响因子: --
作者:
de Wit E;van Doremalen N;Falzarano D;Munster VJ
通讯作者: Munster VJ
DOI: 10.2337/dc20-1521
发表时间: 2020-12
期刊: Diabetes care
影响因子: 16.2
作者:
Solerte SB;D'Addio F;Trevisan R;Lovati E;Rossi A;Pastore I;Dell'Acqua M;Ippolito E;Scaranna C;Bellante R;Galliani S;Dodesini AR;Lepore G;Geni F;Fiorina RM;Catena E;Corsico A;Colombo R;Mirani M;De Riva C;Oleandri SE;Abdi R;Bonventre JV;Rusconi S;Folli F;Di Sabatino A;Zuccotti G;Galli M;Fiorina P
通讯作者: Fiorina P
DOI: 10.1007/s00125-012-2592-3
发表时间: 2012-09-01
期刊: DIABETOLOGIA
影响因子: 8.2
作者:
Lee, Y. -S.;Park, M. -S.;Jun, H. -S.
通讯作者: Jun, H. -S.
DOI: 10.1111/dom.14097
发表时间: 2020-07-01
影响因子: 5.8
作者:
Fadini, Gian Paolo;Morieri, Mario Luca;Avogaro, Angelo
通讯作者: Avogaro, Angelo
DOI: 10.1507/endocrj.ej12-0158
发表时间: 2012-10-20
期刊: ENDOCRINE JOURNAL
影响因子: 2
作者:
Kirino, Yasushi;Sei, Masako;Sato, Youichi
通讯作者: Sato, Youichi